Pancreatic cancer (PC) is acquired postnatally; to mimic this scenario, we developed an inducible KrasG12D; Ptf1a-CreERTM (iKC) mouse model, in which Kras is activated postnatally at week 16 upon tamoxifen (TAM) administration. The gene discussed is KRAS; the disease is familial pancreatic carcinoma.